VS Narayana Murty Darisipudi

Dr. VS Narayana Murty Darisipudi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2018 in Microorganisms
Verified
Journal Article
Open access
PDF file
VDVS Narayana Murty Darisipudi
VS Narayana Murty Darisipudi
MNMaria Nordengrün
Maria Nordengrün
BBBarbara Bröker
Barbara Bröker
VPVincent Peton
Vincent Peton
Staphylococcus aureus (S. aureus) is a dangerous pathogen as well as a frequent colonizer, threatening human health worldwide. Protection against S. aureus infection is challenging, as the bacteria have sophisticated strategies to escape the host immune response. To maintain equilibrium with S. aureus, both innate and adaptive immune effector mechanisms are required. Dendritic cells (DCs) are critical players at the interface between the two arms of the immune system, indispensable for inducing specific T cell responses. In this review, we highlight the importance of DCs in mounting innate as well as adaptive immune responses against S. aureus with emphasis on their role in S. aureus-induced respiratory diseases. We also review what is known about mechanisms that S. aureus has adopted to evade DCs or manipulate these cells to its advantage.

16 January 2024 in mBio
Verified
Journal Article
Open access
JGJuan José Izquierdo Gonzalez
Juan José Izquierdo Gonzalez
FHFaruq Hossain
Faruq Hossain
JNJolanda Neef
Jolanda Neef
EZErin E. Zwack
Erin E. Zwack
CTChih-Ming Tsai
Chih-Ming Tsai
VDVS Narayana Murty Darisipudi
VS Narayana Murty Darisipudi
The iron-regulated surface determinant protein B (IsdB) of Staphylococcus aureus is involved in the acquisition of iron from hemoglobin. Moreover, IsdB elicits an adaptive immune response in mice and humans. Here, we show that IsdB also has impact on innate immunity. IsdB induces the release of proinflammatory cytokines, including IL-6 and IL-1β, in innate immune cells of humans and mice. In silico analysis and thermophoresis show that IsdB directly binds to TLR4 with high affinity. TLR4 sensing was essential for the IsdB-mediated production of IL-6, IL-1β, and other cytokines as it was abolished by blocking of TLR4-MyD88-IRAK1/4-NF-κB signaling. The release of IL-1β additionally required activation of the NLRP3 inflammasome. In human monocytes infected with live S. aureus , IsdB was necessary for maximal IL-1β release. Our studies identify S. aureus IsdB as a novel pathogen-associated molecular pattern that triggers innate immune defense mechanisms. IMPORTANCE: The prevalence of multidrug-resistant Staphylococcus aureus is of global concern, and vaccines are urgently needed. The iron-regulated surface determinant protein B (IsdB) of S. aureus was investigated as a vaccine candidate because of its essential role in bacterial iron acquisition but failed in clinical trials despite strong immunogenicity. Here, we reveal an unexpected second function for IsdB in pathogen-host interaction: the bacterial fitness factor IsdB triggers a strong inflammatory response in innate immune cells via Toll-like receptor 4 and the inflammasome, thus acting as a novel pathogen-associated molecular pattern of S. aureus . Our discovery contributes to a better understanding of how S. aureus modulates the immune response, which is necessary for vaccine development against the sophisticated pathogen.

18 March 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
LOLiliane Maria Fernandes de Oliveira
Liliane Maria Fernandes de Oliveira
MSMarina Steindorff
Marina Steindorff
VDVS Narayana Murty Darisipudi
VS Narayana Murty Darisipudi
DMDaniel Mrochen
Daniel Mrochen
PTPatricia Trübe
Patricia Trübe
SHSilva Holtfreter
Silva Holtfreter
Due to increasing mupirocin resistance, alternatives for Staphylococcus aureus nasal decolonization are urgently needed. Adhesion inhibitors are promising new preventive agents that may be less prone to induce resistance, as they do not interfere with the viability of S. aureus and therefore exert less selection pressure. We identified promising adhesion inhibitors by screening a library of 4208 compounds for their capacity to inhibit S. aureus adhesion to A-549 epithelial cells in vitro in a novel automated, imaging-based assay. The assay quantified DAPI-stained nuclei of the host cell; attached bacteria were stained with an anti-teichoic acid antibody. The most promising candidate, aurintricarboxylic acid (ATA), was evaluated in a novel persistent S. aureus nasal colonization model using a mouse-adapted S. aureus strain. Colonized mice were treated intranasally over 7 days with ATA using a wide dose range (0.5–10%). Mupirocin completely eliminated the bacteria from the nose within three days of treatment. In contrast, even high concentrations of ATA failed to eradicate the bacteria. To conclude, our imaging-based assay and the persistent colonization model provide excellent tools to identify and validate new drug candidates against S. aureus nasal colonization. However, our first tested candidate ATA failed to induce S. aureus decolonization.

26 August 2021 in EBioMedicine
Verified
Journal Article
Open access
VDVS Narayana Murty Darisipudi
VS Narayana Murty Darisipudi
BBBarbara Bröker
Barbara Bröker

5 September 2025 in bioRxiv
Verified
Preprint
Open access
LHLiliane Maria Fernandes Hartzig
Liliane Maria Fernandes Hartzig
SPShruthi Peringathara
Shruthi Peringathara
VDVS Narayana Murty Darisipudi
VS Narayana Murty Darisipudi
SSSean Lando Levin Seegert
Sean Lando Levin Seegert
EBElisa Bludau
Elisa Bludau
SHSilva Holtfreter
Silva Holtfreter
Individuals colonized with the pathobiont Staphylococcus aureus can develop endogenous S. aureus infections if the delicate balance between host and microbe is disturbed. We have recently developed a model of persistent S. aureus colonization using the mouse-adapted S. aureus strain JSNZ. This strain is efficiently transferred from the parents to the offspring, leading to lifelong and usually asymptomatic colonization. Here we report that adult male mice frequently develop spontaneous infections of their preputial glands (preputial gland adenitis, PGA), which are characterized by significant pus production and gland enlargement. This study aimed to characterize PGA in terms of phenotype, causative agents, and the pathogen-specific antibody and T cell responses. To this end, we compared naïve mice, S. aureus -colonized PGA-negative mice with S. aureus -colonized, PGA-positive mice. PGA occurred in 8/12 (67%) of the male breeding animals and in 17/25 (68%) of the adult male offspring. The infection was not self-resolving, but persisted for several months. Genotyping revealed that the colonizing S. aureus strain JSNZ was the causative agent of PGA. The infection caused a purulent inflammation, characterized by massive bacterial aggregates and neutrophil infiltrates in the gland lumen leading to complete disruption of the glandular architecture. PGA induced a strong, but localized release of IL-1α, IL-1β, IL-17, MIP-1α and KC in the infected gland. T cells from PGA-draining lymph nodes as well as splenocytes reacted to in vitro re-stimulation with a S. aureus antigen cocktail with the proliferation of Th17 cells, and the release of IL-17 and IFN-γ, corresponding to a type 1/3-immune response. To conclude, the pathology of this spontaneous and chronic S. aureus infection is driven by a strong type 3-biased immune response that is unable to clear the infection. This endogenous PGA model will be a valuable tool for studying host-pathogen interactions in natural S. aureus infections. Author Summary: Around one in five people naturally carry Staphylococcus aureus bacteria in their noses, usually without any problems. But if something upsets the balance—like a cut on the skin or a weakened immune system—these bacteria can cause a range of infections such as boils and abscesses, wound infections, and sepsis. To better understand how this happens, we developed a special mouse model where the mice are colonized with S. aureus in their noses, just like people are. Interestingly, over half of the male mice developed abscesses caused by their colonizing S. aureus strain. Even though the immune system reacted with strong local inflammation, a Th17-driven T cell response and antibody production, the bacteria were not cleared. This well reflects the human situation, where S. aureus infections are often persistent. This new mouse model helps us study exactly what causes the balance to tip, turning harmless bacteria into harmful invaders. By learning more about these triggers, we hope to find better ways to prevent and treat infections caused by S. aureus .

4 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ACArundhasa Chandrabalan
Arundhasa Chandrabalan
PTPierre E Thibeault
Pierre E Thibeault
BSBojan Smiljanov
Bojan Smiljanov
LMLaura A Mittmann
Laura A Mittmann
Stefanie Deinhardt-EmmerStefanie Deinhardt-Emmer
Stefanie Deinhardt-Emmer
VDVS Narayana Murty Darisipudi
VS Narayana Murty Darisipudi
Staphylococcus aureus (S. aureus) is a major cause of life-threatening systemic infection in humans. To cause blood stream infections such as sepsis and endocarditis, the bacteria must overcome the host’s endothelial barrier. The serine protease-like proteins (Spls) of S. aureus are known to contribute to pneumonia and allergic airway inflammation in animal models, but their role in endothelial damage is unknown. Here we demonstrate that SplB induces proinflammatory cytokine release in primary human vascular endothelial cells (HUVECs) in vitro. Mechanistically, we show that SplB selectively cleaves and activates human proteinase-activated receptor-2 (PAR2), and induces biased signaling via β-arrestin-1 and -2 and NF-kβ. This activation did not trigger Gαq/11-mediated calcium release nor ERK phosphorylation. Inhibition of PAR2 in HUVECs reduced the SplB-mediated cytokine release. Intravital microscopy of cremaster muscles in mice demonstrated that administration of SplB causes microvascular leakage. Neutralization of SplB with a monoclonal antibody retained the endothelial barrier. This study identifies PAR2 as a receptor and substrate for SplB and highlights its role in mediating endothelial damage.